Difference between revisions of "Part:BBa K4307042"

 
m
Line 3: Line 3:
 
<partinfo>BBa_K4307042 short</partinfo>
 
<partinfo>BBa_K4307042 short</partinfo>
  
−
waiting
+
In order to enable the engineered bacteria to react to the proteins on the sperm surface,
 +
a protein detection system is constructed in engineered bacteria. We call it affipmrABC system. This system is modified from the two-component system PmrB/A in E.coli. AffiPmrB (BBa_K4307025）protein is the receptor of our system. The extracellular iron (III)-binding motif of PmrB receptor(Trp34 to Glu64) is replaced with another protein named affibody to build AffiPmrB. Affibody is a kind of engineered protein that can recognize Fc fragment of antibody(Stahl et al., 2017). Through our design, bacteria can use antibodies as an intermediate to respond to external protein molecules. PmrA (BBa_K4307026） is corresponding response regulator to mediate cellular responses. PmrC (BBa_K4307027） is the promoter regulated by PmrA. EGFP is the reporter gene of this system.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 9: Line 10:
  
 
<!-- -->
 
<!-- -->
−
<span class='h3bb'>Sequence and Features</span>
+
<h2>Sequence and Features</h2>
 
<partinfo>BBa_K4307042 SequenceAndFeatures</partinfo>
 
<partinfo>BBa_K4307042 SequenceAndFeatures</partinfo>
  
  
 +
<!-- Uncomment this to enable Functional Parameter display
 +
===Functional Parameters===
 +
<partinfo>BBa_K4307000 parameters</partinfo>
 +
<!-- -->
 +
 +
 +
<html>
 +
 +
<h2>Characterization </h2>
 +
 +
<p>The following figure demonstrates our successful construction.</p>
 +
 +
<br>
 +
<p align="center">
 +
<img alt="" src="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042-gel.png" width="50%"  >
 +
</p>
 +
 +
<div class="center">
 +
    <div class="thumb tnone">
 +
        <div class="thumbinner" style="width:50%;">
 +
            <a href="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042-gel.png" class="image">
 +
                <img alt="" src="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042-gel.png" width="100%" height=auto class="thumbimage" /></a>                  <div class="thumbcaption">
 +
                <div class="magnify">
 +
                    <a href="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042-gel.png" class="internal" title="Enlarge"></a>
 +
                </div>
 +
                <b>Figure 1: </b> <b>The construction results of pT7-AffiPmrB-PmrA-PmrC-EGFP.</b>
 +
               
 +
            </div>
 +
        </div>
 +
    </div>
 +
</div>
 +
 +
<h3>Confocal fluorescent microscope assay was done to characterize the bio brick.</h3>
 +
 +
<p>First, IPTG was used to induce the expression of affiPmrB receptor and PmrA protein, and then human IgG antibody was added to the experimental group. Then we detect the fluorescence of EGFP under confocal fluorescence microscope. The experiment shows that compared with the culture medium without antibody, more engineering bacteria produce fluorescence in the culture medium with antibody concentration of 100mM.</p>
 +
 +
<br>
 +
<div class="center">
 +
    <div class="thumb tnone">
 +
        <div class="thumbinner" style="width:50%;">
 +
            <a href="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042.png" class="image">
 +
                <img alt="" src="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042.png" width="100%" height=auto class="thumbimage" /></a>                  <div class="thumbcaption">
 +
                <div class="magnify">
 +
                    <a href="https://static.igem.wiki/teams/4307/wiki/wiki-parts-files/mainpage/bba-k4307042.png" class="internal" title="Enlarge"></a>
 +
                </div>
 +
                <b>Figure 2: </b> <b>The confocal fluorescent microscope photos for validation experiment.</b>Cells without antibody induction(A and C) and cells with antibody induction(B and D) were observed under confocal fluorescence microscope.
 +
               
 +
            </div>
 +
        </div>
 +
    </div>
 +
</div>
 +
 +
<h2>Conclusion</h2>
 +
<p>The EGFP fluorescence intensity of the <i>E.coli</i> which express this part increases after being induced, however the increment is indeed very low, and is rather unstable. Therefore, in order to use the part in diagnose system, we built a new composite part with AffiPmrBAC and amplifier system T7-T3 (BBa_K4307033).</p>
 +
 +
<h2>References</h2>
 +
<p>[1] Chen, H. D., & Groisman, E. A. (2013). The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. <i>Annu Rev Microbiol</i>, 67, 83-112.</p>
 +
<p>[2] Stahl, S., Graslund, T., Eriksson Karlstrom, A., Frejd, F. Y., Nygren, P. A., & Lofblom, J. (2017). Affibody Molecules in Biotechnological and Medical Applications. <i>Trends Biotechnol</i>, 35(8), 691-712.</p>
 +
 +
</html>
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
 
===Functional Parameters===
 
===Functional Parameters===
 
<partinfo>BBa_K4307042 parameters</partinfo>
 
<partinfo>BBa_K4307042 parameters</partinfo>
 
<!-- -->
 
<!-- -->

Revision as of 16:38, 13 October 2022


pT7-AffiPmrB-PmrA-PmrC-EGFP

In order to enable the engineered bacteria to react to the proteins on the sperm surface, a protein detection system is constructed in engineered bacteria. We call it affipmrABC system. This system is modified from the two-component system PmrB/A in E.coli. AffiPmrB (BBa_K4307025）protein is the receptor of our system. The extracellular iron (III)-binding motif of PmrB receptor(Trp34 to Glu64) is replaced with another protein named affibody to build AffiPmrB. Affibody is a kind of engineered protein that can recognize Fc fragment of antibody(Stahl et al., 2017). Through our design, bacteria can use antibodies as an intermediate to respond to external protein molecules. PmrA (BBa_K4307026） is corresponding response regulator to mediate cellular responses. PmrC (BBa_K4307027） is the promoter regulated by PmrA. EGFP is the reporter gene of this system.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 907
    Illegal BamHI site found at 2172
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 2854



Characterization

The following figure demonstrates our successful construction.


Figure 1: The construction results of pT7-AffiPmrB-PmrA-PmrC-EGFP.

Confocal fluorescent microscope assay was done to characterize the bio brick.

First, IPTG was used to induce the expression of affiPmrB receptor and PmrA protein, and then human IgG antibody was added to the experimental group. Then we detect the fluorescence of EGFP under confocal fluorescence microscope. The experiment shows that compared with the culture medium without antibody, more engineering bacteria produce fluorescence in the culture medium with antibody concentration of 100mM.


Figure 2: The confocal fluorescent microscope photos for validation experiment.Cells without antibody induction(A and C) and cells with antibody induction(B and D) were observed under confocal fluorescence microscope.

Conclusion

The EGFP fluorescence intensity of the E.coli which express this part increases after being induced, however the increment is indeed very low, and is rather unstable. Therefore, in order to use the part in diagnose system, we built a new composite part with AffiPmrBAC and amplifier system T7-T3 (BBa_K4307033).

References

[1] Chen, H. D., & Groisman, E. A. (2013). The biology of the PmrA/PmrB two-component system: the major regulator of lipopolysaccharide modifications. Annu Rev Microbiol, 67, 83-112.

[2] Stahl, S., Graslund, T., Eriksson Karlstrom, A., Frejd, F. Y., Nygren, P. A., & Lofblom, J. (2017). Affibody Molecules in Biotechnological and Medical Applications. Trends Biotechnol, 35(8), 691-712.